PLAT and androgen insensitivity syndrome: We have recently shown that IVT delivered through telestroke network is not inferior in terms of safety and efficacy to tissue-type plasminogen activator (tPA) provided at specialized stroke centers for the treatment of AIS in the 3-h time window (9).